Skip to main content
Mantle Cell Lymphoma

Exploring Anaplastic Large Cell Lymphoma: Symptoms, Causes, and Treatment Options

By March 20, 2025March 26th, 2025No Comments

Anaplastic Large Cell Lymphoma (ALCL) is a rare form of cancer within the non-Hodgkin lymphoma group. It occurs when white blood cells, called lymphocytes, grow uncontrollably. Lymphocytes are vital components of your immune system, helping protect the body against infections and diseases.

There are two types of lymphocytes:

  • B cells (B lymphocytes)
  • T cells (T lymphocytes)

In ALCL, T lymphocytes become abnormal and grow in an uncontrolled way. The name “Anaplastic Large Cell Lymphoma” describes the appearance of these abnormal cells under a microscope:

  • Anaplastic: Refers to the strange, irregular appearance of the cancer cells when compared to healthy T cells.
  • Large Cell: The cancerous T lymphocytes appear larger than normal T cells.
  • Lymphoma: This term refers to cancer that originates in the lymphatic system, and in ALCL, it involves the abnormal growth of T lymphocytes.

Types of ALCL

In 2016, the World Health Organization (WHO) classified ALCL into four types:

  • ALK-positive ALCL (ALK+ ALCL)
  • ALK-negative ALCL (ALK− ALCL)
  • Primary Cutaneous ALCL (pcALCL)
  • Breast Implant-Associated ALCL (BIA-ALCL)

ALK-positive and ALK-negative ALCL: These are more aggressive types of ALCL that affect the whole body. The difference between the two is based on the presence of a special protein called ALK.

ALK-positive ALCL: This type has a genetic mutation that results in an overactive ALK protein, leading to rapid cell growth.

ALK-negative ALCL: Although it doesn’t have this genetic mutation, it still has other genetic changes that may contribute to its development.

Primary Cutaneous ALCL (pcALCL): This type is less aggressive and usually affects only the skin. It may appear as a single bump or tumor, typically not spreading to other parts of the body. It can sometimes have some similar genetic changes to ALK-positive ALCL.

Cutaneous T-cell lymphoma (CTCL) is another rare type of non-Hodgkin lymphoma that affects the immune system. Unlike most forms of non-Hodgkin lymphoma, CTCL develops due to mutations in T cells. These abnormal T cells primarily target the skin, leading to the formation of lesions and other skin-related symptoms.

Breast Implant-Associated ALCL (BIA-ALCL): This type of ALCL develops around breast implants, often many years after the implant surgery. It usually causes changes in the breast’s texture, shape, or pain in the area. Unlike other types of ALCL, BIA-ALCL tends to remain localized to the area around the implant.

Overall, ALCL is a complex condition with different types that vary in how aggressively they spread and how they behave. Understanding the type of ALCL a person has is crucial for determining the best treatment.

Diagnosis of Anaplastic Large Cell Lymphoma

Anaplastic Large Cell Lymphoma (ALCL) is diagnosed by examining tissue samples under a microscope. The defining feature of ALCL is the presence of unusual cells, known as “hallmark cells”. These cells have distinct, irregularly shaped nuclei (often kidney- or horseshoe-shaped), a prominent Golgi body, and they express a specific protein on their surface called CD30.

Causes of Anaplastic Large Cell Lymphoma (ALCL)

ALCL occurs when lymphocytes (a type of white blood cell) grow uncontrollably and invade healthy tissues. While the exact cause is unknown, researchers have identified key genetic mutations linked to the disease.

Genetic Mutations and ALCL

  • ALK Gene Mutation: Found in ALK-positive ALCL, this mutation causes abnormal ALK protein production, leading to rapid cell growth.
  • Other Genetic Changes: Different mutations are linked to ALK-negative ALCL and other subtypes, contributing to the transformation of healthy cells into cancerous ones.

Although the specific triggers behind these mutations remain unclear, ongoing research aims to uncover what causes normal lymphocytes to turn cancerous.

Signs and Symptoms of Anaplastic Large Cell Lymphoma (ALCL)

ALCL can cause a variety of symptoms depending on the type and where the cancer is located in the body. Here are the key signs to watch for:

1. Swollen Lymph Nodes

One of the most common symptoms of ALCL is enlarged lymph nodes. These are small, bean-shaped structures that help fight infections and are located in various parts of the body, including the neck, armpits, and groin. In ALCL, the lymph nodes can swell due to the uncontrolled growth of abnormal T lymphocytes. These swollen nodes may feel firm, painless, and rubbery, but in some cases, they can be tender.

2. Fever, Unexplained Weight Loss, and Night Sweats

These symptoms, often called B symptoms, indicate that the lymphoma is affecting the entire body. They include:

  • Fever: Persistent or recurring fevers without an apparent infection.
  • Unintentional Weight Loss: Losing weight rapidly without dieting or exercise.
  • Night Sweats: Heavy sweating, especially at night, soaking through clothing and sheets.

These symptoms may suggest that ALCL is progressing and affecting the body more systemically.

3. Skin Lesions (for Primary Cutaneous ALCL – pcALCL)

In primary cutaneous ALCL (pcALCL), the cancer mainly affects the skin, leading to:

  • Red or purple skin lumps (nodules or plaques)
  • Ulcers or open sores that may not heal properly
  • Patches of irritated or thickened skin

These lesions are usually localized to one area, such as the arms, legs, or trunk, and they may grow slowly over time. However, in some cases, multiple skin areas may be affected. Unlike other types of ALCL, pcALCL rarely spreads to internal organs or lymph nodes.

If you notice any of these symptoms, it is important to seek medical attention, as early diagnosis and treatment can improve outcomes.

Mantle Cell Lymphoma

Discover promising treatment options and innovative therapies.

Enroll in a Mantle Cell Lymphoma Clinical Trial

Treatment Options for Anaplastic Large Cell Lymphoma (ALCL)

The treatment for ALCL depends on the subtype, stage of the disease, and overall health of the patient. Here are the primary treatment approaches:

1. Chemotherapy and Targeted Therapies

  • Chemotherapy is the most common treatment for systemic ALCL (ALK-positive and ALK-negative). It involves using powerful drugs to kill cancer cells or stop them from growing. The standard chemotherapy regimen is CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone).
  • Targeted Therapies focus on attacking specific proteins or pathways in cancer cells.
    • Brentuximab vedotin is a targeted drug used for ALCL that expresses the CD30 protein.
    • ALK inhibitors may be effective in ALK-positive ALCL by blocking the abnormal ALK protein.

2. Radiation Therapy

  • Radiation is used to shrink tumors in localized ALCL or relieve symptoms in advanced cases.
  • It may be combined with chemotherapy for better outcomes.

3. Surgical Options for Breast Implant-Associated ALCL (BIA-ALCL)

  • BIA-ALCL develops around breast implants, and the primary treatment is surgical removal of the implant and surrounding scar tissue (capsulectomy).
  • In most cases, surgery alone is effective, but if the disease has spread, chemotherapy or radiation may be needed.

Also Read: Immunotherapy vs Chemotherapy: Understanding the Difference in Cancer Treatment

What is Oncology Research?

Oncology research focuses on understanding, preventing, diagnosing, and treating cancer. It involves studying cancer cells, genetics, and new therapies to improve patient outcomes. Researchers explore innovative treatments like immunotherapy, targeted drugs, and precision medicine to develop more effective and less toxic cancer treatments.

A key aspect of oncology research is the importance of clinical trials, which test new treatments for safety and effectiveness. These trials help advance medical knowledge and offer patients access to cutting-edge therapies that may improve survival and quality of life.

Mantle Cell Lymphoma

Discover promising treatment options and innovative therapies.

Enroll in a Mantle Cell Lymphoma Clinical Trial

Conclusion

Anaplastic Large Cell Lymphoma (ALCL) is a rare form of non-Hodgkin lymphoma, with different subtypes affecting prognosis and treatment approaches. Advances in targeted therapies and chemotherapy have significantly improved survival rates, particularly for ALK-positive ALCL. Early diagnosis plays a crucial role in effective treatment and ongoing Mantle Cell Lymphoma clinical trials continue to explore innovative therapies to enhance patient outcomes.

Frequently Asked Questions

Is anaplastic large cell lymphoma curable

The curability of Anaplastic Large Cell Lymphoma (ALCL) depends on the subtype, stage, and treatment response. ALK-positive ALCL generally has a better prognosis and is often curable with chemotherapy. ALK-negative ALCL is more aggressive but can still be treated successfully in some cases. Primary cutaneous ALCL and BIA-ALCL typically have high survival rates, with BIA-ALCL often being cured through complete surgical removal. Early diagnosis and appropriate treatment significantly improve outcomes.

What are the first signs of ALCL?

A common symptom of ALCL is enlarged lymph nodes—small, bean-shaped structures that help the body fight infections. These swollen lymph nodes can appear in different areas, such as the neck, armpits, and groin.

What is the survival rate of anaplastic large cell lymphoma?

Survival rates for ALCL vary by subtype. ALK-positive ALCL has a five-year survival rate of 33% to 90%, while ALK-negative ALCL ranges from 13% to 74%, depending on factors like cancer type and IPI score. Primary cutaneous ALCL has an 80% five-year survival rate, though it may recur. BIA-ALCL is often curable with complete surgical removal.

How long does it take for Bia-ALCL to develop?

Symptoms may develop as early as one year after implant surgery or take several years to appear. On average, they begin around eight years after the procedure.